BofA/Merrill Lynch Downgrades PTC Therapeutics (PTCT) to Neutral

February 29, 2016 8:58 AM

BofA/Merrill Lynch downgraded PTC Therapeutics (NASDAQ: PTCT) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found